MedPath

Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry

Recruiting
Conditions
Turner Syndrome
Registration Number
NCT05052606
Lead Sponsor
University of Colorado, Denver
Brief Summary

INSIGHTS is a registry research study that collects key information on medical history for girls and women with Turner syndrome and the clinical care they receive. This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. In addition to learning a lot about the current state of health for individuals with TS, INSIGHTS serves as an infrastructure to conduct future studies are meaningful to patients and their families.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
5000
Inclusion Criteria
  1. Individuals with TS and TS variants as defined by the TS Clinical Practice Guideline definition (karyotype consistent with TS, phenotypic female, clinical feature(s) of TS)
  2. Informed consent/assent as appropriate
Read More
Exclusion Criteria

a. Lack of a TS diagnosis on file

Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Health conditionsFrom study start until condition observed, up to 15 years

Average number of chronic diagnoses per person

Secondary Outcome Measures
NameTimeMethod
Prevalence of hearing lossFrom study start until condition observed, up to 15 years

Prevalence of hearing loss is defined as the number of participants in the sample formally diagnosed with a hearing loss in their medical record in a clinical encounter, problem list, and/or past medical history or an audiology report consistent with hearing impairment out of the total sample.

Prevalence of mental health diagnosesFrom study start until condition observed, up to 15 years

Prevalence of mental health diagnoses is defined as the number of participants in the sample diagnosed with a mental health disorder by a clinician according to their medical record out of the total sample. This will be determined by a diagnosis of any of the following in a clinical encounter, problem list, and/or past medical history:

* Depression

* Anxiety

* Mood disorder NOS

* Psychotic disorder

* Attention-deficit/hyperactivity disorder (ADHD)

* Autistic disorder

Prevalence of premature ovarian insufficiencyFrom study start until condition observed, up to 15 years

Prevalence of premature ovarian insufficiency is defined as the number of participants in the sample with a diagnosis of premature ovarian insufficiency (or failure) in their medical record clinical encounter, problem list, and/or past medical history or laboratory results in their medical record consistent with this diagnosis (elevated FSH or undetectable AMH) out of the total sample.

Cardiometabolic diagnoses - prevalence of obesityFrom study start until condition observed, up to 15 years

Prevalence of obesity is defined as the number of participants in the sample with obesity in their medical record out of the total sample. Obesity in pediatric populations is determined using BMI-for-age and obesity in adult populations is determined using BMI. BMI is calculated as the weight in kilograms divided by the height in meters squared.

Participants will be considered to have obesity if:

* There is a diagnosis of obesity in the medical record in a clinical encounter, problem list, and/or past medical history

* For children 17 years and younger: there is an available growth chart/height/weight/other data necessary to calculate the BMI-for-age and the BMI-for-age is at or above the 95th percentile

* For adults 18 years and older: there is a BMI at or above 30 kg/m2 or the data necessary to calculate BMI and it is at or above 30 kg/m2

Cardiometabolic diagnoses - prevalence of hypertensionFrom study start until condition observed, up to 15 years

Prevalence of hypertension is defined as the number of participants in the sample with evidence of hypertension in their medical record out of the total sample. Evidence of hypertension includes:

* Formal diagnosis of hypertension in a clinical encounter, problem list, and/or past medical history

* For children under 13 years old: a blood pressure reading at or above the 95th percentile for age, height, and sex

* For children between 13 and 17 years old: a blood pressure reading at or above 130/80 mmHg

* For adults 18 years or older: a blood pressure reading at or above 140/90 mmHg

Cardiometabolic diagnoses - prevalence of dyslipidemiaFrom study start until condition observed, up to 15 years

Prevalence of metabolic syndrome is defined as the number of participants in the sample with dyslipidemia in their medical record out of the total sample. Dyslipidemia will be defined as:

* Diagnosis of dyslipidemia, hypertriglyceridemia, hypercholesterolemia in a clinical encounter, problem list, and/or past medical history

* Laboratory evidence of elevated total cholesterol, LDL, triglycerides, and/or low HDL for sex and age

Cardiometabolic diagnoses - prevalence of fatty liver diseaseFrom study start until condition observed, up to 15 years

Prevalence of fatty liver disease is defined as the number of participants in the sample with a formal diagnosis of fatty liver disease in their medical record out of the total sample. Fatty liver disease diagnosis in the medical record in a clinical encounter, problem list, and/or past medical history may also present as:

* Non-alcoholic fatty liver disease (NAFLD)

* Hepatic steatosis

* Simple fatty liver disease

* Non-alcoholic steatohepatitis

Trial Locations

Locations (10)

Nationwide Childern's Hospital

🇺🇸

Columbus, Ohio, United States

Children's Hospital Colorado

🇺🇸

Aurora, Colorado, United States

Children's National

🇺🇸

Washington, District of Columbia, United States

Lurie Children's

🇺🇸

Glenview, Illinois, United States

University of Kansas

🇺🇸

Lawrence, Kansas, United States

UNC Hospitals Children's Specialty Clinic

🇺🇸

Chapel Hill, North Carolina, United States

Cincinnati Children's Hospital Medical Center

🇺🇸

Cincinnati, Ohio, United States

Children's Hospital of Philadelphia

🇺🇸

Philadelphia, Pennsylvania, United States

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

Seattle Children's

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath